We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
A Practical Look at Cardiorenal Protection for CKD in T2D: Applying Recent Data
Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Maria Luiza Caramori, MD, PhD, MSc
Ana Maria Cebrián-Cuenca, MD, PhD
Pam R. Taub, MD, FACC, FASPC
A Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
Antoni Bayés-Genís, MD, PhD, FESC, FHFA
Patrick Rossignol, MD, PhD
Main Messages of New ESC Guidelines for CVD Management in Diabetes
First ESC Guidelines on Cardiomyopathies Management
Update of ESC Guidelines on Heart Failure in a Nutshell
What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA
Stephen J. Greene, MD, FACC, FHFSA
Bridging the Gap to Care: What You Need to Know About ATTR-CM Amyloidosis
Mazen Hanna, MD
Marianna Fontana, MD
What Is the Totality of Evidence for IV Iron Treatment Outcomes in Patients with Heart Failure?
Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
Ovidiu Chioncel, MD, PhD
Marco Metra, MD
Addressing Patient Management in ASCVD Risk Reduction: A Collaborative Approach
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Charles P. Vega, MD
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
Nirav Y. Raval, MD, FACC
Gurusher Panjrath, MD, FACC, FAHA, FHFSA
2022 ERS/ESC PAH Guidelines on Echocardiography
Jean M. Elwing, MD
Implications of Aggressive Therapy in ‘PAH Without Comorbidities’
Rajan Saggar, MD
2022 ERS/ESC PH Guidelines on Diagnosis
Hot Topics from the New ERS/ESC Guidelines: Definitions and Risk Assessment
Richard N. Channick, MD
Ioana Preston, MD
Essential Aspects of the New ERS/ESC Treatment Guidelines: Patients Without Comorbidities
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education